돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 628812생성일: 2026년 10월 25일

Bendamustine Hydrochloride → Bendamustine hydrochloride monohydrate

https://huagongshe.com/reaction/628812

반응식

참여 물질

역할이름HCID투입량
반응물Bendamustine HydrochlorideHCID 77082—
용매WaterHCID 962—
생성물Bendamustine hydrochloride monohydrateHCID 66600935—

반응 단계

In one aspect of the present invention, the wet bendamustine hydrochloride monohydrate is obtained from a crystallization, recrystallization, trituration or precipitation procedure, wherein the wet bendamustine hydrochloride monohydrate is present in solid, particulate form in admixture with a solvent system comprising water in which the bendamustine hydrochloride monohydrate is substantially insoluble and then separated from the bulk of the solvent system by a method such as filtration, decantation, centrifugation or the like to provide the wet bendamustine hydrochloride monohydrate. For example, a relatively crude portion of bendamustine hydrochloride may be recrystallized from a solvent system comprised of water and collected by one of the aforementioned methods to provide a cake (e.g., a filter cake), which may be washed one or more times with additional solvent (which may be the same as, or different from, the solvent system utilized in the recrystallization). In one embodiment of the invention, the filter cake of bendamustine hydrochloride monohydrate is washed with water and then t-butyl methyl ether to provide the wet bendamustine hydrochloride monohydrate. Generally speaking, it will be preferred to avoid the use of acetone in such a washing step, since the solubility of bendamustine hydrochloride monohydrate in acetone or aqueous acetone tends to result in unacceptably high yield losses.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09315469B2
출처 데이터셋uspto-grants-2016_04
ORD IDord-ad0ef1f347fa4fe8a69fbcc27b915025
출처 메모uspto-grants-2016_04